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Skin as an important site of drug application for both local and systemic effects. However in 
skin, the stratum corneum is the main barrier for drug penetration. Penetration enhancement 
technology is a challenging development that would increase the number of drugs available 
for transdermal administration. The permeation of drug through skin can be enhanced by both 
chemical penetration enhancement and physical methods. In this review, we have discussed 
the chemical penetration enhancement technology for transdermal drug delivery as well as 
the probable mechanisms of action.  
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Introduction 
 
The transdermal route now ranks with oral 
treatment as the most successful innovative 
research area in drug delivey, with around 
40% of the drug delivery candidate products 
under clinical evaluation related to 
transdermal or dermal system. The worldwide 
transdermal patch market approaches £ 2 
billion, based on only ten drugs including 
scopolamine, nitroglycerine, clonidine, 
estrogen, testosterone, fentanyl, and nicotine, 
with a lidocaine patch soon to be marketed
1
. 
The success of a dermatological drug to be 
used for systemic drug delivery depends on 
the ability of the drug to penetrate through 
skin in sufficient quantities to achieve the 
desired therapeutic effect
3
. In this article, we 
review some uses of the more widely 
investigated chemical penetration enhancers 
and discuss their possible mechanisms of 
action. 
 
Transdermal drug delivery is the 
administration of a therapeutic agent through 
intact skin for systemic effect. Transdermal 
drug delivery offers the following advantages 





• Avoidance of hepatic first pass 
metabolism. 
• Ability to discontinue administration by 
removal of the system. 
• The ability to control drug delivery for a 
longer time than the usual 
gastrointestinal transit of oral dosage 
form. 
• The ability to modify the properties of the 
biological barrier to absorption. 
 
The method employed for modifying the 
barrier properties of the stratum corneum to 
enhance drug penetration and absorption 





1. Chemical enhancement 
2. Physical enhancement 
3. Biochemical enhancement 
4. Supersaturation enhancement 
5. Bioconvertable prodrug 
 
A brief review of skin structure 
 
The skin can be considered to have four 




1. Non-viable epidermis (stratum corneum) 
2. Viable epidermis 
3. Viable dermis  
4. Subcutaneous connective tissue (hypo-
dermis)  
 
Non-viable epidermis (stratum corneum)  
 
Stratum corneum is the outer most layer of 
skin, which is the actual physical barrier to 
most substance that come in contact with the 
skin. The stratum corneum is 10 to 20 cell 
layer thick over most of the body.  Each cell is 
a flat, plate-like structure - 34-44 µm long, 25-
36 µm wide, 0.5 to 0.20 µm thick - with a 
surface area of 750 to 1200 µm
2 
stocked up to 
each other in brick like fashion. Stratum 
corneum consist of lipid (5-15%) including 
phospholipids, glycosphingolipid, cholesterol 
sulfate and neutral lipid, protein (75-85%) 
which is mainly keratin.   
 
Viable epidermis  
 
This layer of the skin resides between the 
stratum corneum and the dermis and has a 
thickness ranging from 50- 100 µm
. 
The 
structure of the cells in the viable epidermis 
are physiochemically similar to other living 
tissues. Cells are held together by tonofibrils. 
The density of this region is not much different 




Just beneath the viable epidermis is the 
dermis. It is a structural fibrin and very few 
cells are like it can be found histologically in 
normal tissue. Dermis thickness range from 
2000 to 3000 µm and consists of a matrix of 
loose connective tissue composed of fibrous 
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protein embedded in an amphorphose ground 
substance.      
 
Subcutaneous connective tissue  
 
The subcutaneous tissue or hypodermis is not 
actually considered a true part of the 
structured connective tissue is composed of 
loose textured, white, fibrous connective 
tissue containing blood and lymph vessels,  
secretory pores of the sweat gland and 
cutaneous nerves. Most investigators consider 
drug permeating through the skin enter the 
circulatory system before reaching the 
hypodermis, although the fatty tissue could 
serve as a depot of the drug.    
 
Pathway of transdermal permeation 
 




1. Transdermal permeation, through the 
stratum corneum. 
2. Intercellular permeation, through the 
stratum corneum. 
3. Transappendaged permeation, via the 
hair follicle, sebaceous and sweat 
glands.  
 
Most molecules penetrate through skin via 
intercellular microroute and therefore many 
enhancing techniques aim to disrupt or 
bypass its elegant molecular architecture. 
 
Ideal characteristics of chemical 
penetration enhancers 
 
Ideally, penetration enhancers reversibly 
reduce the barrier resistance of the stratum 
corneum without damaging viable cells
13,14
. 
Some of the more desirable properties for 
penetration enhancers acting within the skin 




• They should be non-toxic, non-irritating 
and non-allergenic 
• They would ideally work rapidly; the 
activity and duration of effect should be 
both predictable and reproducible. 
• They should have no pharmacological 
activity within the body. 
• The penetration enhancers should work 
unidirectionally, i.e., they should allow 
therapeutic agents into the body whilst 
preventing the loss of endogenous 
materials from the body. 
• When removed from the skin, barrier 
properties should return both rapidly and 
fully to normal. 
• They should be cosmetically acceptable 
with an appropriate skin feel.  
 
Not surprisingly, no such material that 
possesses the above ideal properties has yet 
been discovered although some chemicals 
demonstrate several of the above attributes.  
 
Mechanism of chemical penetration 
enhancement 
 
Penetration enhancers may act by one or 




1. Disruption of the highly ordered structure 
of stratum corneum lipid. 
2. Interaction with intercellular protein. 
3. Improved partition of the drug, co-
enhancer or solvent into the stratum 
corneum.  
 
The enhancer act by altering one of three 
pathways. The key to altering the polar 
pathway is to cause protein conformational 
change or solvent swelling. The fatty acid 
enhancers increased the fluidity of the lipid 
protein portion of the stratum corneum. Some 
enhancers act on both polar and nonpolar 
pathway by altering the multilaminate pathway 
for penetration. Enhancers can increase the 
drug diffusivity through skin proteins. The type 
of enhancer employed has a significant impact 
on the design and development of the 
product
2
. A useful way to consider factors 
affecting drug permeation rate through the 
stratum corneum is via the simple equation 
given below for steady state flux
1
. If we plot 
the cumulative mass of diffusant, m,  passing 
per unit area through the membrane , at long 
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time the graph approaches linearity and its 
slope its yield the steady flux , dm/dt 
 
     dm/dt  = D Co K /h---------------------------- (1) 
 
where Co is the constant concentration of drug 
in donor solution, K is the partition coefficient 
of the solute between the membrane and the 
bathing solution, D is the diffusion coefficient 
and h is thickness of membrane. 
 
From the above equation, we deduce the ideal 
properties of a molecule that would 
penetrating stratum corneum well. These are: 
 
• Low molecular mass, preferably less 
than 600Da, when D tends to be high. 
• Adequate solubility in oil and water so 
that membrane concentration gradient 
may be high. 
• High but balanced (optimal) K (if too 
large, may inhibit clearance by viable 
tissue) 
• Low melting point, correlating with good 
solubility as predicted by ideal solubility 
theory. 
 
Chemical penetration enhancers 
 
 Chemical substances temporarily diminishing 
the barrier of the skin and known as 
accelerants or sorption promoters can 
enhance drug flux. Several types are known 
 
Sulphoxides and similar chemicals  
 
Dimethyl sulphoxides (DMSO) is one of the 
earliest and most widely studied penetration 
enhancers. It is a powerful aportic solvent 
which hydrogen bonds with itself rather than 
with water. It is colourless, odourless and is 
hydroscopic and is often used in many areas 
of pharmaceutical sciences as a “universal 
solvent”. DMSO alone has been applied 
topically to treat systemic inflammation. 
DMSO works rapidly as a penetration 
enhancer - spillage of the material onto the 
skin can be tasted in the mouth within a 
second. Although DMSO is an excellent 
accelerant, it does create problems. The effect 
of the enhancer is concentration-dependent 
and generally cosolvents containing > 60% 
DMSO are needed for optimum enhancement 
efficacy. However, at these relative high 
concentrations, DMSO can cause erythema 
and wheal of the stratum corneum. Denaturing 
of some skin proteins results in erythema, 





Since DMSO is problematic for use as a 
penetration enhancer, researchers have 
investigated a similar chemically-related 
material as a accelerant. DMAC and DMF are 
similarly powerful aportic solvents. However, 
Southwell and Barry, showing a 12-fold 
increase in the flux of caffeine permeating 
across a DMF-treated human skin, concluded 
that the enhancer caused irreversible 
membrane damage
7
. DMF irreversibly 
damages human skin membranes but has 
been found in vivo to promote the 
bioavailability of betamethasone-17-benzoate 
as measured by vasoconstrictor assay
8,9
. 
DMSO may also extract lipids, making the 
horny layer more permeable by forming 
aqueous channels
12
. The mechanism of the 
sulphoxide penetration enhancers is widely 
used to denature protein and, on application 
to human skin, has been shown to change the 
intercellular keratin conformation, from α  






Azone (1-dodecylazacycloheptan-2-one or 
laurocapran) was the first molecule 
specifically designed as a skin penetration 
enhancer. Azone is a colourless, odourless 
liquid with a melting point of -7 ºC and it 
possesses a smooth, oily but yet non-greasy 
feel. Azone is a highly lipophilic material with a 
log p octanol / water of around 6.2 and it is 
soluble in and compatible with most organic 
solvents including alcohol and propylene 
glycol. Azone enhances the skin transport of a 
wide variety of drugs including steroids, 
antibiotics and antiviral agents. Azone is most 
effective at low concentrations, being 
employed typically between 0.1- 5% but more 
Inayat and Setty 
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often between 1- 3% 
13
. Azone partitions into 
a bilayer lipid to disrupt their packing 
arrangement but integration into the lipid is 
unlikely to be homogeneous. Azone 
molecules may exist dispersed within the 







Pyrrolidones have been used as permeation 
enhancers for numerous molecules including 
hydrophilic (e.g. mannitol and 5-flurouracil) 
and lipophilic (progesterone and 
hydrocortisone) permeants. N-methyl-2-
pyrolidone was employed with limited success 
as a penetration enhancer for captopril when 
formulated in a matrix-type transdermal 
patch
15
. The pyrrolidones partition well into 
human stratum corneum within the tissue and 
they may act by altering the solvent nature of 
the membrane. Pyrrolidones have been used 
to generate reservoirs within the skin 
membrane. Such a reservoir effect offers a 
potential for sustained release of a permeant 





Fatty acids  
 
Percutaneous drug absorption has been 
increased by a wide variety of long-chain fatty 
acids, the most popular of which is oleic acid. 
It is of interest to note that many penetration 
enhancers such as azone contain saturated or 
unsaturated hydrocarbon chains and some 
structure - activity relationships have been 
drawn from the extensive studies of Aungst 
who employed a range of fatty acids, acids, 
alcohols, sulphoxides, surfactants and amides 
as enhancers for naloxone
17,18
. Shin et al
19
 
studied various penetration enhancers like 
glycols (diethylene glycol and tetraethylene 
glycol), fatty acids (lauric acid, myristic acid 
and capric acid) and nonic surfactant 
(polyoxyethylene-2-oleyl ether, polyoxy 
ethylene-2-stearly ether) on the release of 
triprolidone. Lauric acid in Propylene glycol 
enhanced the delivery of highly lipophilic 
antiestrogen
20
. Oleic acid greatly increased 
the flux of many drugs such as increasing the 
flux of salicylic acid 28-fold and 5-flurouracil 
flux 56-fold through human skin membrane in 
vitro
21
. The enhancer interacts with and 
modifies the lipid domains of the stratum 
corneum as would be expected for a long-




Essential oil, terpenes and terpenoids 
 
Terpenes are found in essential oils, and are 
compounds comprising of only carbon, 
hydrogen and oxygen atoms, but which are 
not aromatic. Numerous terpenes have long 
been used as medicines as well as flavoring 
and fragrance agents. The essential oils of 
eucalyptus, chenopodium and ylang-ylang 
have been found to be effective penetration 
enhancers for 5-flouorouracil transversing 
human skin in vivo
22
. Cornwell et al
23
 
investigated the effect of 12 sesquiterpenes 
on the permeation of 5-flurouracil in human 
skin. Pretreatment of epidermal membranes 
with sesquiterpene oil or using solid 
sesquiterpenes saturated in dimethyl 
isosorbide increased the absorption of 5-
flurouracil. L-menthol has been used to 
facilitate in vitro permeation of morphine 
hydrochloride through hairless rat skin
24
 as 
well as diffusion of imipramine hydrochloride 





One mechanism by which this agent operates 
is to modify the solvent nature of the stratum 
corneum, thus improving drug partitioning into 
the tissue. Many terpenes permeate human 
skin well and large amounts of terpene have 
been found in the epidermis after application 
from a matrix-type patch. Terpenes may also 
modify drug diffusivity through the membrane. 
During steady state permeation experiments 
using terpenes as penetration enhancers, the 
lag time for permeation was usually reduced, 
indicating some increase in drug diffusivity 
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Oxazolidinones are a new class of chemical 
agents which have the potential for use in 
many cosmetic and personal care product 
formulations. This is due to their ability to 
localize co-administered drug in skin layers, 
resulting in low systemic permeation
27,28
. The 
structural features of these permeation 
enhancers are closely related to sphingosine 
and ceramide lipids which are naturally found 
in the upper skin layers. Oxazolidinones such 
as 4-decyloxazolidin-2-one has been reported 
to localize the delivery of many active 
ingredients such as retinoic acid and 
diclofenac sodium in skin layers
29
. This 
compound has a higher molecular weight and 
lipophilicity than other solvent-type enhancers, 
physical characteristics that may be beneficial 
in terms of a reduction in local toxicity 
because of the lack of effective absorption of 
these enhancers into the lower skin layers 




Urea promotes transdermal permeation by 
facilitating hydration of the stratum corneum 
and by the formation of hydrophilic diffusion 
channels within the barrier. Cyclic urea 
permeation enhancers are biodegradable and 
non-toxic molecules consisting of a polar 
parent moiety and a long chain alkyl ester 
group. As a result, enhancement mechanism 
may be a consequence of both hydrophilic 






Skin permeation enhancement technology is a 
rapidly developing field which would 
significantly increase the number of drugs 
suitable for transdermal drug delivery, with the 
result that skin will become one of major 
routes of drug administration in the next 
decade. Research in this area has proved the 
usefulness of chemical penetration enhancers 
in the enhancement of drug permeation 
through skin. The chemical penetration 
enhancement methods discussed in this 
review are promising. Focus should be on skin 
irritation with a view to selecting penetration 
enhancers which possess optimum 
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